Hello, we’re human HUMN,
nice to meet you.
Curiosity, Ingenuity, Passion & Excellence
The strongest medicine that exists for a human being is another human being and thus our organization stands by the values shared by all of our people. We like to believe that we have put together something extraordinary; a rare group of seasoned and successful people at the top of their careers to bring about a new vision, revolutionary products and ethical change. We know that making a difference in the world requires the very best intentions and actions. It requires real human connection; the ability to feel the heart of another. This is at the very core of who we are and what we do. It is what makes us HUMN.
Executive Management Team
Blair J. McInnes
Founder And Chairman Of The Board
Blair J. McInnes
Founder and Chairman of the Board
Blair McInnes, the Founder and Chairman of the Board, is a seasoned entrepreneur and a visionary leader whose career is marked by a series of successful ventures that have consistently filled market voids with innovative solutions. With a keen eye for identifying unmet needs and a clear vision for market niches, Blair has spent several decades at the forefront of founding, managing, and investing in companies that have made significant market impacts.
As the president of a Canadian company, Blair demonstrated his strategic prowess by expanding its market reach into the United States, transforming it into a multi-million-dollar enterprise. His astute business acumen was further evident when he skillfully negotiated the acquisition of a Canadian IT company, successfully introducing it to the US public market. This strategic move not only broadened the company’s access to capital but also significantly enhanced its shareholder value.
Eight years ago, Blair identified a unique opportunity in the pharmaceutical marketplace. Driven by his conviction that everyone is entitled to affordable, safe, and effective natural products, he provided the seed capital to establish Humn Pharmaceuticals. Under his guidance, the company has been meticulously crafted to develop formulations that address unmet needs, focusing on delivering products that perform as intended while being accessible and affordable.
Blair’s leadership extends beyond strategic direction. He actively collaborates with his research teams, contributing to the development of innovative products that meet the demands in areas where solutions are scarce. Concurrently, he works closely with his sales team, orchestrating the establishment of robust distribution channels that ensure these groundbreaking products reach beyond Canada, penetrating markets in the United States and Europe.
Blair McInnes’s journey is a testament to his commitment to innovation, excellence, and his unwavering belief in making a positive impact on the health and wellbeing of people globally. His leadership continues to drive Humn Pharmaceuticals forward, shaping it into a company that stands at the intersection of innovative healthcare solutions and market needs.
Art Pemberton
President And Chief Operating Officer
Art Pemberton
President And Chief Operating Officer
Art boasts a distinguished career spanning over three decades, marked by strategic leadership and executive roles within both private and public international corporations. Widely recognized as a catalyst for growth, he has been instrumental in establishing and expanding dominant, vertically integrated structures for two of Canada’s top companies with a global market presence.
In his former role as President, CEO, and board member of a $500 million conglomerate, Art adeptly steered the company’s multifaceted operations, encompassing manufacturing, wholesale, and retail sectors, and directly overseeing more than 5,000 employees. His holistic approach encompassed key areas such as operations, information technology, human resources, legal affairs, and finance, significantly enhancing sales and profitability.
Art’s expertise extends to corporate restructuring and financial optimization, particularly in mergers, acquisitions, and business turnarounds. Notably, as President/COO of a prominent retail chain in North America, he successfully orchestrated the acquisition and swift revamp of a retail chain from bankruptcy. This strategic move facilitated the remarkable reopening of sixty-four stores in a single day, showcasing his adeptness in rapid implementation and financial stewardship. This restructuring not only salvaged the chain but also substantially boosted the acquiring company’s profits, marking a financial turnaround that continues to yield millions in annual savings and revenue.
Currently, Art is channeling his profound industry experience and visionary leadership into guiding Humn Pharmaceuticals. His focus lies in steering the company’s strategic product development, driving growth through mergers and acquisitions, and meticulously crafting the infrastructure necessary for its evolution into a publicly traded entity. With his forward-thinking approach and proven track record, Art is set to propel Humn Pharmaceuticals to new heights in the pharmaceutical industry.
Management
Tessa Hart
Director Of Sales And Marketing
Rodger Lundon
Manager Client Services
Rodger Lundon
Manager Client Services
Rodger excels in his role as Manager of Client Services, where his extensive background in retailing and business administration significantly enhances his performance. His comprehensive expertise, encompassing inventory management, human resources, and supply chain functions, alongside his proficiency in back-office administration systems, positions him uniquely to oversee and optimize client service operations.
In this pivotal role, Rodger is not only responsible for ensuring the smooth functioning of various operational aspects but also for maintaining a client-centric approach. His ability to integrate and manage diverse business facets allows him to deliver exceptional service, addressing client needs effectively and efficiently. His leadership in the Client Services department is instrumental in cultivating strong client relationships, driving client satisfaction, and fostering loyalty, thereby contributing significantly to the overarching success and reputation of the organization.
Michael van der Horn
Manager Information Technology
Michael van der Horn
Manager Information Technology
Michael van der Horn is an accomplished IT professional with over two decades of diverse experience in the technology sector, specializing in IT program and project management. As the Manager of IT, Michael brings a wealth of knowledge and a proven track record in leading complex IT projects, driving technological innovation, and spearheading digital transformation initiatives.
With a strong foundation in systems analysis and a deep understanding of formal systems delivery methodologies, including Agile/Scrum, SAFe Agile, and Waterfall, Michael has consistently demonstrated excellence in aligning IT strategies with business objectives. His tenure at companies like Pacific Blue Cross and Peoples Group is marked by successful implementations of significant IT projects, showcasing his ability to navigate the complexities of the industry and deliver solutions that enhance operational efficiency and productivity.
Michael holds a Master of Business Administration from SFU Beedie School of Business and a B.Sc. in Software Engineering from NHL University of Applied Sciences. His educational background, coupled with his hands-on experience, positions him as a strategic leader in the pharmaceutical industry, driving IT initiatives that support innovation, growth, and competitive advantage.
As the Manager of IT, Michael is committed to fostering a culture of continuous improvement, leveraging cutting-edge technologies to advance healthcare solutions, and ensuring that IT systems are robust, secure, and compliant with the highest standards of the pharmaceutical industry.
Greg Herron
Executive Director UK
Greg Herron
Executive Director UK
As a highly accomplished international sales and marketing executive, this professional has honed an impressive array of skills and cultivated an extensive network of relationships across the global market. His expertise is not just in forging connections but in nurturing and maintaining these relationships over the years, a testament to his commitment and understanding of the intricate dynamics of global sales activities.
With a career marked by active involvement in international markets, he possesses deep-rooted business acumen and communication skills, both of which are directly tied to and have been refined through his operational roles. His professional journey is distinguished by a wealth of experience garnered from living and working in numerous overseas locations, providing him with a unique and comprehensive understanding of diverse market landscapes and cultural nuances.
This blend of global experience, strategic relationship management, and operational proficiency makes him an invaluable asset, especially in environments that demand a nuanced understanding of international sales and marketing strategies, cultural intelligence, and the ability to navigate complex global markets with agility and finesse.
Chris Moss
Director of Special Projects
Chris Moss
Director of Special Projects
Chris Moss is a distinguished figure in the medical, pharmaceutical, and surgical sales sector, boasting an impressive career that spans four decades. His exceptional track record is punctuated by national accolades for highest sales and profit performance, underscoring his profound expertise and dedication.
Chris’s tenure has been marked by the cultivation of an extensive network, establishing enduring relationships across a wide spectrum of professionals in the medical, surgical, and pharmaceutical industries. This network encompasses a diverse array of customers and end-users, medical and surgical specialists, buyers, managers, and key decision-makers within buying groups, as well as health regulatory and legislative authorities.
Renowned for his in-depth knowledge of a vast array of products in the surgical, medical, and OTC pharmaceutical fields, Chris’s expertise extends to product applications and functionalities. This comprehensive understanding has earned him numerous sales distinctions and accolades, including being recognized as the top Canadian performer, consistently securing the “lion’s share” of his market.
At the heart of Chris’s approach is a customer-first philosophy, a testament to years of dedicated problem-solving and trusted advisory within his territory. His strong belief in collaboration and teamwork is rooted in his athletic background, tracing back to high school and university days. This foundation has been instrumental in fostering robust relationships with his working associates over the years.
Now part of the Humn Pharmaceuticals team, Chris brings his long-standing reputation, unparalleled sales prowess, and innate ability to network and unite people. His contribution is not just an addition but a significant enhancement to the dynamic management group at Humn Pharmaceuticals, promising to propel the company further in its pursuit of excellence and innovation in the pharmaceutical industry.
Board of Directors
Blair J. McInnes
Founder And Chairman Of The Board
Blair J. McInnes
Founder and Chairman of the Board
Blair McInnes has as spent several decades founding, running, and investing in companies that addressed an unfulfilled need with a clear and executable vision of their market niche. As president of a Canadian company, he expanded its market into the United States where it established itself as a multi-million-dollar enterprise. McInnes also negotiated the acquisition of a Canadian IT company and brought it into the US public market to expand both the company’s access to capital as well as its shareholder value. Eight years ago, he saw what he believed to be a unique opportunity in the pharmaceutical marketplace and provided the seed capital to found Humn Pharmaceuticals. Fueled by his belief that everyone deserves affordable natural products that are safe and perform as intended, he assembled experienced management and research teams and focused the company to develop formulations that filled this void, eventually expanding these products beyond Canada and into the United States and Europe. Working with his research teams, Blair continues to help address the development of products that satisfy the demand for products in areas lacking solutions. In parallel, he coordinates with his sales team to establish distribution channels for these products.
Art Pemberton
President And Chief Operating Officer
Art Pemberton
President And Chief Operating Officer
Art boasts a distinguished career spanning over three decades, marked by strategic leadership and executive roles within both private and public international corporations. Widely recognized as a catalyst for growth, he has been instrumental in establishing and expanding dominant, vertically integrated structures for two of Canada’s top companies with a global market presence.
In his former role as President, CEO, and board member of a $500 million conglomerate, Art adeptly steered the company’s multifaceted operations, encompassing manufacturing, wholesale, and retail sectors, and directly overseeing more than 5,000 employees. His holistic approach encompassed key areas such as operations, information technology, human resources, legal affairs, and finance, significantly enhancing sales and profitability.
Art’s expertise extends to corporate restructuring and financial optimization, particularly in mergers, acquisitions, and business turnarounds. Notably, as President/COO of a prominent retail chain in North America, he successfully orchestrated the acquisition and swift revamp of a retail chain from bankruptcy. This strategic move facilitated the remarkable reopening of sixty-four stores in a single day, showcasing his adeptness in rapid implementation and financial stewardship. This restructuring not only salvaged the chain but also substantially boosted the acquiring company’s profits, marking a financial turnaround that continues to yield millions in annual savings and revenue.
Currently, Art is channeling his profound industry experience and visionary leadership into guiding Humn Pharmaceuticals. His focus lies in steering the company’s strategic product development, driving growth through mergers and acquisitions, and meticulously crafting the infrastructure necessary for its evolution into a publicly traded entity. With his forward-thinking approach and proven track record, Art is set to propel Humn Pharmaceuticals to new heights in the pharmaceutical industry.
Connie Clerici
Director Designate
Connie Clerici
Director Designate
Connie Clerici is a visionary leader and a seasoned executive with an extensive track record of steering large teams through the intricacies of a complex and highly regulated healthcare environment. As the founder and CEO of a prominent healthcare corporation, Connie has been at the forefront of channeling resources towards the advancement of medical innovations while steadfastly supporting and enhancing a high-quality, publicly funded healthcare system in Canada.
Under Connie’s strategic leadership, Closing the Gap Healthcare has flourished, employing over 2000 healthcare professionals who deliver a comprehensive continuum of professional services. These services span Nursing, Physiotherapy, Occupational Therapy, Speech and Language Pathology, Social Work, Personal Support, Dietetics, and future care cost consulting services. Connie’s unwavering dedication lies in aiding society’s most vulnerable, upholding a strong sense of accountability, and ensuring that ethical, compassionate practices are at the core of sound business operations.
A life-long learner, Connie’s educational journey is as impressive as her professional one, with extensive leadership and business training from prestigious institutions like Ivey, Rotman, Schulich, McMaster, and York Universities, alongside participation in numerous values-based training programs. Her commitment to academia and policy development is evident through her roles as an Adjunct Lecturer at the University of Toronto’s Institute for Health Policy, Management and Evaluation, and as a board member or advisor at various esteemed institutions and organizations.
Connie’s profound impact on healthcare, entrepreneurship, and the broader business community has not gone unnoticed, earning her numerous accolades including the Mississauga Board of Trade Business Award of Excellence, the Queen Elizabeth II Diamond Jubilee Medal, and induction into the Hall of Fame of Canada’s Most Powerful Women: Top 100, among others.
Beyond her professional endeavors, Connie is deeply engaged in community service, contributing her expertise to various health committees, advisory boards, and councils. Her roles have included crucial contributions during the COVID-19 pandemic, optimizing healthcare strategies and resources, and ongoing involvement in digital health and innovation working groups.
Connie Clerici’s journey is a testament to her passion for enhancing life enjoyment through healthcare, her commitment to making a positive impact in the lives of Canadians, and her dedication to fostering innovation and excellence in the healthcare sector.
Technical Board
Dr Jason Crosby – Orthopedic Surgeon
Technical Board
Dr Jason Crosby – Orthopedic Surgeon
Technical Board
Dr. Crosby, a native of Winnipeg, Manitoba, has charted an impressive academic and professional journey in the field of Orthopedic surgery. Beginning with foundational studies at the University of Manitoba, where he completed his Bachelor of Science, undergraduate MD, and Orthopedic residency, Dr. Crosby furthered his expertise with a series of prestigious sub-specialization fellowships. These included training in Arthroscopy and Athletic Injuries at UBC, Vancouver, a Lower Limb Fellowship in Trauma and Orthopedics in Norwich, England, and advanced studies in Hip and Knee Arthroplasty and Reconstruction in Sydney, Australia.
Commencing his practice in 2009, Dr. Crosby has since become a respected figure in the Manitoba medical community, known for his dual focus on elective arthroplasty and sports arthroscopy. His affiliation with esteemed institutions like the Grace Hospital and Pan Am Clinic underscores his commitment to delivering top-notch orthopedic care.
In 2018, Dr. Crosby took a significant step forward in his career by co-founding Fort Whyte Orthopedics with three partners. This venture represents not just growth but a vision to establish a comprehensive musculoskeletal health facility, offering an expansive array of services from minor injury treatment to potentially private care services and surgical suites.
Beyond his clinical and entrepreneurial endeavors, Dr. Crosby’s dedication shines through his involvement in Operation Walk. This medical mission, which he proudly participates in, embodies his commitment to making life-changing healthcare accessible, particularly by offering joint replacements to those in Nicaragua who lack such medical opportunities.
Dr. Crosby’s role on the Technical Advisory Board of Humn Pharmaceuticals is marked by a fusion of medical expertise and a broad knowledge base. His diverse skill set, encompassing leadership, time management, and communication skills, along with his passion, dedication, and commitment to lifelong learning and embracing new challenges, makes him an invaluable asset to the board and the wider medical community.
Ken Carroll
Technical Board
Ken Carroll
Technical Board
Ken Carroll is a distinguished legal professional whose career, spanning over four decades, has been characterized by a profound dedication to the practice of law and business consultancy. Graduating from Robson Hall, University of Manitoba, in 1978, Ken’s legal expertise, particularly in corporate, commercial, and real estate law, has positioned him as a trusted advisor to a wide array of clients, from local startups to international corporations.
Ken’s professional journey has been marked by a deep involvement with start-up companies across various industries. His role has been pivotal in steering these nascent ventures from their foundational stages to successful, thriving businesses. His extensive knowledge of law, coupled with a keen understanding of organizational structures and due diligence processes, makes him an invaluable resource in the business realm.
His recent transition from active law practice to a more direct involvement in business activities marks a new chapter in his career, one where his profound legal acumen and business insights are set to foster growth and innovation. Ken’s ability to assess new business opportunities, contribute meaningfully to business relationships and negotiations, and craft strategic corporate organizations are instrumental in guiding new enterprises towards market success. His influence extends beyond legal counsel, shaping the very strategies that drive businesses forward.
Bev Wilson
Technical Board
Bev Wilson
Technical Board
Bev is a Natural Health Practitioner dedicated to health, wellness, and conscious business, with a profound commitment to compassion. With over four decades of experience, Bev’s professional and personal life weaves a rich tapestry of achievement, innovation, and heartfelt contribution. Her notable career led to pivotal roles in hospitals, nursing homes, corporations, and entrepreneurial endeavors.
Life presented Bev with personal health challenges in the form of Fibromyalgia and Chronic Fatigue in the early ‘90s. Undeterred, Bev embarked on a transformative journey of self-healing, and training of over 30 natural health therapies. She also investigated and used numerous health products with safe, effective pain relief, and sleep promotion at the top of her list. Bev’s entrepreneurial spirit flourished as she established her own natural health centre, imparting her knowledge and expertise to thousands.
TPR20 is the reason Bev and her husband Stew got involved in the company. Then ‘Get Sleeping’ changed their lives by helping them sleep and improving their brain health. This combined with the HUMN Team’s ethical business practices, and profound caring for their customers, affiliates, and investors makes Bev and Stew proud to be involved in HUMN Pharma.
Bankers Capital International
Technical Board
Bankers Capital International
Technical Board
Bankers Capital International (BCI), under the astute leadership of Founder and Senior Executive Director Todd DeMatteo, has proudly taken on the role of Investment Banker on the Advisory Board of HUMN. BCI, a boutique investment bank headquartered in the bustling heart of New York City, boasts a client-centric approach, with a special focus on institutional clients and the vast expanse of global markets.
BCI’s commitment to excellence and its comprehensive understanding of the intricate financial landscape enables it to adeptly assist clients in navigating through a myriad of business opportunities. Specializing in areas such as mergers and acquisitions (M&As), capital raises, restructuring, and turnarounds, the firm is well-equipped to offer strategic planning and advisory services. Its reach spans across major global markets, including North America, Europe, Asia, and Russia, ensuring a broad and inclusive perspective on the ever-evolving global economic environment.
As HUMN’s chosen Investment Banker, BCI’s partnership signifies a strategic alignment of expertise and vision, poised to further HUMN’s growth and success in its endeavors. For those seeking to delve deeper into the services and expertise offered by Bankers Capital International, more information is available on their official website at bankerscapitalinternational.com.
Finding your passion isn’t just about finding a career and money. It is about learning to relinquish the ego and finding your authentic self. Although we are in the business of helping people, we set forth a culture where our people do not bury their personal needs beneath the needs of others. We understand that balance.